<?xml version="1.0" encoding="UTF-8"?>
<p id="p0034" num="0034" sourceFile="EPÂ 1380573B1.xml">The compound of Formula (II) may be converted into another compound of Formula (II). Monohalogenated alkenedioates of Formula (IIb) (
  <i>e.g.,</i> X is Cl or F; his 1):
  <!-- EPO <DP n="18"> -->
  <chemistry id="chem0007" num="0007">
    <img id="ib0012" file="imgb0012.tif" wi="91" he="52" img-content="chem" img-format="tif" orientation="portrait" inline="no"/>
  </chemistry> may be prepared by a process which involves elimination of hydrogen halide (HX
  <sup>2</sup>) from vicinal dihalo alkanedioates of Formula (IIa) (
  <i>e.g.,</i> X
  <sup>1</sup> and X
  <sup>2</sup> are independently Cl or F; T is hydroxyl or halide; h is 1): 
  <chemistry id="chem0008" num="0008">
    <img id="ib0013" file="imgb0013.tif" wi="92" he="51" img-content="chem" img-format="tif" orientation="portrait" inline="no"/>
  </chemistry>
</p>
